The Effects of the PsyPills App on Emotion Regulation and Risk Behaviors in Emerging Adults: A Randomized Clinical Trial
NCT07304830 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 204
Last updated 2025-12-26
Summary
This study aims to investigate the effects of the PsyPills mobile application on improving emotion regulation and reducing risk behaviors among emerging adults. PsyPills is a self-guided psychological intervention based on Rational-Emotive and Behavioral Therapy (REBT) principles and the Just-in-Time Adaptive Intervention (JITAI) framework. The app provides short, contextually adaptive "psychological pills," or cognitive restructuring exercises, designed to help users replace irrational beliefs with rational alternatives in moments of emotional distress. The study will compare PsyPills app with an active control condition using the MoodWheel app, which supports emotional monitoring without therapeutic content.
Conditions
- Emotion Regulation Difficulties; Risky Behaviors (Substance Use, Risky Sexual Behavior, Self-harm, Aggression, Disordered Eating)
Interventions
- BEHAVIORAL
-
PsyPills
A self-guided mobile intervention based on Rational-Emotive and Behavioral Therapy (REBT) principles and the Just-in-Time Adaptive Intervention (JITAI) framework. Provides short, adaptive "psychological pills" - personalized cognitive restructuring exercises aimed at identifying and replacing irrational beliefs, reducing dysfunctional emotionality, and improving emotion regulation.
- BEHAVIORAL
-
MoodWheel
The active control condition involves using the MoodWheel app, designed for emotional self-monitoring without therapeutic content. Participants label and track their emotional states, but the app does not provide cognitive restructuring, feedback, or intervention elements.
Sponsors & Collaborators
-
Babes-Bolyai University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 29 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-31
- Primary Completion
- 2026-04-30
- Completion
- 2026-05-31
Countries
- Romania
Study Locations
More Related Trials
-
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
NCT00353938 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
NCT01793610 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of the Prosocial and Prosexual Effects of GHB
NCT02342366 ·Status: COMPLETED ·Phase: NA
-
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
NCT05570708 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
NCT03752918 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effects of MDMA-like Substances in Healthy Subjects
NCT04847206 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin's Effect on Socioemotional Aging
NCT01823146 ·Status: COMPLETED ·Phase: NA
-
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
NCT01458327 ·Status: COMPLETED ·Phase: PHASE2
-
Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers
NCT01404754 ·Status: COMPLETED ·Phase: PHASE1
-
Buspirone for the Treatment of Traumatic Brain Injury (TBI) Irritability and Aggression
NCT01821690 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
NCT06884514 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of GABA Modulator AZD7325 on Cortical Excitability
NCT02135198 ·Status: COMPLETED ·Phase: PHASE1
-
MDMA in Borderline Personality Disorder
NCT06683014 ·Status: RECRUITING ·Phase: PHASE2
-
Oxytocin Administration and Emotion Recognition Abilities in Adults Reporting Adverse Childhood Experiences
NCT03335085 ·Status: COMPLETED ·Phase: NA
-
Animal-assisted Placebo-induced Analgesia
NCT03898141 ·Status: COMPLETED ·Phase: NA
-
Effect of Methylenedioxymethamphetamine (MDMA) (Serotonin Release) on Fear Extinction
NCT03527316 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Drugs on Responses to Brain and Emotional Processes
NCT04053036 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting
NCT01151696 ·Status: COMPLETED ·Phase: PHASE4
-
Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study
NCT00779324 ·Status: COMPLETED ·Phase: NA
-
MDMA for AUD/PTSD Comorbidity
NCT05943665 ·Status: RECRUITING ·Phase: PHASE2
-
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
NCT05709353 ·Status: RECRUITING ·Phase: PHASE2
-
Role of Serotonin in Acute and Subacute MDMA Effects
NCT00838305 ·Status: COMPLETED ·Phase: NA
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Qualitative Study About Psychedelics Using in Psychiatric Disorders
NCT06014164 ·Status: NOT_YET_RECRUITING
-
Prosocial Effects of MDMA
NCT05948683 ·Status: COMPLETED ·Phase: EARLY_PHASE1